Vaxart shares slide after first-quarter earnings miss

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Vaxart shares slide after first-quarter earnings miss

To read the full story on Seeking Alpha, click here.

Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Vaxart Charts.

Vaxart (NASDAQ:VXRT)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Vaxart Charts.

Vaxart Inc News

Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers
Tuesday 30 April 2024 (1 day ago) • GlobeNewswire Inc.

Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
Wednesday 27 March 2024 (1 month ago) • GlobeNewswire Inc.

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wednesday 20 March 2024 (1 month ago) • GlobeNewswire Inc.

Vaxart Provides Business Update and Reports Full Year 2023 Financial Results
Thursday 14 March 2024 (2 months ago) • GlobeNewswire Inc.

U.S. Stock Futures Rise Ahead Of PPI and Retail Sales; Oil Prices Climb
Thursday 14 March 2024 (2 months ago) • IH Market News

Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14
Thursday 7 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director
Wednesday 6 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 15 February 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Tuesday 13 February 2024 (3 months ago) • Edgar (US Regulatory)

Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 Challenge
Monday 5 February 2024 (3 months ago) • GlobeNewswire Inc.

More Vaxart Inc News Articles

Global Developments (PK)

FBEC Worldwide (PK)

Yuenglings Ice Cream (PK)

CBD of Denver (PK)

Elite Pharmaceuticals (QB)

Mullen Automotive

Virexit Technologies (PK)

Tonner One World (PK)

Branded Legacy (PK)

International Star (PK)

BlueFire Equipment (PK)

Impact Fusion (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions